Does Pharma get a bad rap?
Reflecting on two fantastic days at the Dynamic Global Events (DGE) "Chief Commercial Officer Summit."
I spent the last few days in a room with about fifty of the most passionate and dedicated people I have ever met. Their deep and sincere commitment to the patients who ultimately benefit from their tireless efforts is inspiring.
It was primarily a learning exercise for me as I don't get that much exposure to the pre-commercial complexities of how a drug moves from concept (molecule) to ultimate approval and availability to the patients in need.
(Mobile Locker focuses on helping the field teams access and engage HCPs with their value insights. That business process, though critical to the success of a brand, comes much later in the journey.)
The path to creating, funding, testing, proving, and ultimately getting a therapy approved and prepared to launch commercially is as complex and intricate as one can imagine. In fact, it is hard to comprehend.
The investments these companies make are astronomical for each drug in development. Some will spend billions and not have a single assurance that the drug will ever see the market!
I know that drugs are too expensive, sometimes not accessible for all, and can come with other enormous challenges. Most of which the pharma companies are working to solve.
I am left to wonder how many more lives could be impacted with a significantly less costly and rigorous development process. Drugs would invariably be cheaper and more accessible, faster. But safety concerns are paramount, as they should be...resulting in a really tough balance.
Thank you to all of the new friends and colleagues I met this week for the amazing content and collaboration and your incredible commitment to the vision of a world without disease.
Special thanks to Robert Francomano for your fantastic leadership and to John Fair, Amy Mahery, Markus Hinderberger, Anindita (Ani) Sinha, Kelli Tea, MBA, Victor M. Clavelli, Cristina Larkin, Mel Hayes, Heather Reinhardt Hays, CPB, Brian Fox and to all the speakers who made this such a tremendous experience (sorry if I missed you.)
You all have really tough jobs, and I admire your unrelenting perseverance. Please keep at it!
It was a privilege to be with you.
#pharmaindustry #DGEvents
Wow! It's great to see this! 🔔 🔔 🔔